0001209191-21-006330.txt : 20210129 0001209191-21-006330.hdr.sgml : 20210129 20210129201913 ACCESSION NUMBER: 0001209191-21-006330 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210127 FILED AS OF DATE: 20210129 DATE AS OF CHANGE: 20210129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Layman Melissa CENTRAL INDEX KEY: 0001806204 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36287 FILM NUMBER: 21573787 MAIL ADDRESS: STREET 1: C/O FLEXION THERAPEUTICS, INC. STREET 2: 10 MALL ROAD, STE. 301 CITY: BURLINGTON STATE: MA ZIP: 01803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Flexion Therapeutics Inc CENTRAL INDEX KEY: 0001419600 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 MALL ROAD STREET 2: SUITE 301 CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: (781) 305-7777 MAIL ADDRESS: STREET 1: 10 MALL ROAD STREET 2: SUITE 301 CITY: BURLINGTON STATE: MA ZIP: 01803 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-27 0 0001419600 Flexion Therapeutics Inc FLXN 0001806204 Layman Melissa C/O FLEXION THERAPEUTICS, INC. 10 MALL ROAD, SUITE 301 BURLINGTON MA 01803 0 1 0 0 Chief Commercial Officer Common Stock 2021-01-27 4 A 0 30000 0.00 A 91000 D Common Stock 2021-01-28 4 S 0 2624 12.55 D 88376 D On April 1, 2020, the Reporting Person was granted 30,000 restricted stock units. The vesting of the shares under the restricted stock unit award was to be based on the achievement of a specified amount of 2020 revenues from ZILRETTA product sales established at the time of the Compensation Committee's approval of the restricted stock unit award. On January 27, 2021, the Compensation Committee certified the achievement of a specified amount of 2020 revenues from ZILRETTA product sales resulting in the commencement of vesting of 30,000 shares. The Reporting Person previously reported the restricted stock units in Table II of Form 4. Sale of shares to cover income tax withholding obligations associated with the vesting of a restricted stock unit award granted to the Reporting Person on April 1, 2020. /s/ Mark S. Levine, Attorney-in-Fact 2021-01-29